logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
06/11/2025
Trader: Novo Nordisk stock is expected to rise 3% - 5% in the morning session.
Latest
2 m ago
Jefferies raised the target price for Arm from $173 to $205; HSBC raised the target price for Arm from $95 to $105.
3 m ago
UK October construction PMI 44.1, expected 46.7, previous value 46.2.
4 m ago
UBS: Cathay Pacific (00293.HK) repurchasing Qatar Airways shares expected to have a positive market response, target price of 12.2 Hong Kong dollars.
4 m ago
Indonesia has stopped approving specific nickel ore processing projects in order to address the issue of oversupply.
5 m ago
Viva Biotech (688321.SH): Application for clinical trial of TheoLonide capsules in the treatment of metastatic pancreatic ductal adenocarcinoma has been accepted.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.